samples cohort
Evidence from:
primary |
all sources
No related entities found.
Mentioned in (40)
Papers in which this entity is mentioned.
- Comprehensive repertoire of the chromosomal alteration and mutational signatures across 16 cancer types. (2026)
- Whole-genome landscapes of 1,364 breast cancers. (2026)
- Integrated single-cell multiomic profiling of caudate nucleus suggests key mechanisms in alcohol use disorder. (2025)
- Parent-of-origin effects on complex traits in up to 236,781 individuals. (2025)
- Principles and methods for transferring polygenic risk scores across global populations. (2024)
- The landscape of drug sensitivity and resistance in sarcoma. (2024)
- Explainable multiview framework for dissecting spatial relationships from highly multiplexed data. (2022)
- Research Review: A guide to computing and implementing polygenic scores in developmental research. (2022)
- Inferring gene expression from cell-free DNA fragmentation profiles. (2022)
- Feasibility of whole genome and transcriptome profiling in pediatric and young adult cancers. (2022)
- Evaluating the transcriptional fidelity of cancer models. (2021)
- kataegis: an R package for identification and visualization of the genomic localized hypermutation regions using high-throughput sequencing. (2021)
- Biologically informed deep neural network for prostate cancer discovery. (2021)
- Characterizing genetic intra-tumor heterogeneity across 2,658 human cancer genomes. (2021)
- Immuno-genomic landscape of osteosarcoma. (2020)
- Tutorial: a guide to performing polygenic risk score analyses. (2020)
- Pan-cancer landscape of homologous recombination deficiency. (2020)
- Germline variants associated with leukocyte genes predict tumor recurrence in breast cancer patients. (2019)
- A Compendium of Mutational Signatures of Environmental Agents. (2019)
- CALDER: Inferring Phylogenetic Trees from Longitudinal Tumor Samples. (2019)
- Circular DNA elements of chromosomal origin are common in healthy human somatic tissue. (2018)
- Enter the Matrix: Factorization Uncovers Knowledge from Omics. (2018)
- Genome doubling shapes the evolution and prognosis of advanced cancers. (2018)
- The Immune Landscape of Cancer. (2018)
- Characterizing genetic intra-tumor heterogeneity across 2,658 human cancer genomes (2018)
- HRDetect is a predictor of BRCA1 and BRCA2 deficiency based on mutational signatures. (2017)
- Integrative clustering of multi-level 'omic data based on non-negative matrix factorization algorithm. (2017)
- Scalable whole-exome sequencing of cell-free DNA reveals high concordance with metastatic tumors. (2017)
- Global analysis of somatic structural genomic alterations and their impact on gene expression in diverse human cancers. (2016)
- FACETS: allele-specific copy number and clonal heterogeneity analysis tool for high-throughput DNA sequencing. (2016)
- Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression. (2016)
- Estimating telomere length from whole genome sequence data. (2014)
- Somatic rearrangements across cancer reveal classes of samples with distinct patterns of DNA breakage and rearrangement-induced hypermutability. (2013)
- Signatures of mutational processes in human cancer. (2013)
- ACMG clinical laboratory standards for next-generation sequencing. (2013)
- Emerging landscape of oncogenic signatures across human cancers. (2013)
- A cross-sample statistical model for SNP detection in short-read sequencing data. (2012)
- Alt Event Finder: a tool for extracting alternative splicing events from RNA-seq data. (2012)
- Genomic regions identified by overlapping clusters of nominally-positive SNPs from genome-wide studies of alcohol and illegal substance dependence. (2011)
- High-resolution mapping of copy-number alterations with massively parallel sequencing. (2009)
Merged raw entities (6)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| samples | cohort | 43 | 51 |
| target sample | cohort | 7 | 12 |
| primary samples | cohort | 4 | 4 |
| target samples | cohort | 4 | 4 |
| dna samples | cohort | — | — |
| stock dnas | cohort | — | — |